Nexeon MedSystems Inc. reported consolidated earnings results for the second quarter ended June 30, 2018. Consolidated revenues for the second quarter of 2018 were $2.8 million, a 68% increase from pro forma consolidated revenues of $1.7 million for the second quarter of 2017. Total manufacturing sales were $2.8 million, an increase of 82% from pro forma manufacturing revenues of $1.5 million for the second quarter of 2017. Gross profit was $0.8 million or 28.5% gross margin, an increase from pro forma gross profit of $0.7 million, or 41.8% gross margin, in the second quarter of 2017. Net loss was $0.7 million or $0.37 per share compared to a pro forma net loss of $1.4 million or $0.80 per share in the second quarter of 2017.